NiKang Therapeutics
John Salinas has over 20 years of work experience in the pharmaceutical industry. John began their career in 2000 as a Sr. Project Manager/ Manufacturing Technical Services at Cardinal Health, Inc. In 2006, they joined Genentech, Inc (A Member of the Roche Group) as a Sr. Contract Manufacturing Manager, CMC and Sr. Project Manager (CMC/Technical Transfers). In 2012, they moved to Acucela Inc. as a Sr. Program Manager. In 2014, they joined Raptor Pharmaceuticals as an Associate Director, Technical Operations Manufacturing, CMC. In 2016, they joined Reata Pharmaceuticals, Inc. as Director Of Manufacturing, CMC. Currently, they are employed as a Sr. Director, Drug Product Development and Manufacturing at NiKang Therapeutics Inc.
John Salinas attended The University of New Mexico.
This person is not in any offices
NiKang Therapeutics
NiKang Therapeutics, Inc. is a privately-held biotech company focused on developing novel small molecule oncology drug discovery. Their mission is to discover and develop first-in-class, and/or best-in-class small molecule targeted therapies and immuno-oncology (I-O) drugs to help cure cancers.